🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#VEITH24: Ellen Dillavou details use of the SelfWrap device (VenoStent), designed to improve AV fistula outcomes, and latest trial data.

#VEITH24: Studies of HemoWrap device for post-cannulation hemostasis show it is safe and effective and has high patient satisfaction, says Sundaram Ravikumar. VEITHsymposium

#VEITH24: C. Keith Ozaki delivers data from RCT comparing Humacyte tissue-engineered vessel vs. autologous AV fistula in end-stage renal patients. VEITHsymposium

#VEITH24: Mahmood Razavi delivers six-month data from the Wrapsody AV access cell-permeable endoprothesis pivotal trial, specifically on the AV graft anastomosis cohort for the first time. VEITHsymposium

New research recently published in The Lancet Healthy Longevity suggest that post-operative diet and exercise guidance can be beneficial for #HRQoL in patients that have received a kidney transplant, but that maintaining these improvements can prove to be challenging renalinterventions.net/improving-hrqo…

.Rockwell Medical, a healthcare company that develops, manufactures, commercialises, and distributes a portfolio of haemodialysis products to dialysis providers worldwide, today announced that Jesse Neri was promoted to chief financial officer (CFO) renalinterventions.net/rockwell-medic…

.RevBio recently announced that the US FDA has accepted its investigational new drug (IND) application for Gemini renalinterventions.net/revelation-bio…

At VEITHsymposium 2024, Robert E Lee, a medical officer recently retired from the U.S. FDA, presented his argument for when the use of RCTs for the regulation and approval of novel vascular access devices becomes important renalinterventions.net/veith-audience…

As a part of the 2024 VEITHsymposium, Ellen Dillavou presented new data about the SelfWrap (VenoStent) bioabsorbable perivascular wrap, outlining how the novel device can, in her words, improve arteriovenous fistula (AVF) maturation and patency renalinterventions.net/novel-bioabsor…

Centers for Medicare & Medicaid Services is opening a national coverage analysis on renal denervation, with a view to reviewing and developing a national Medicare coverage policy for the therapy for patients with hypertension Medtronic Recor Medical renalinterventions.net/cms-launches-r…

.MediBeacon has won FDA approval for the MediBeacon TGFR system for the assessment of kidney function in patients with normal or impaired renal function. TGFR uses an intravenous Lumitrace injection but does not require blood draws or urine analysis renalinterventions.net/medibeacon-us-…

Great to speak with Maarten Snoeijs at #EVC2025 to discuss this year’s vascular access programme at the meeting as well as the ongoing OASIS trial. Stay tuned for the video interview #VascularAccess #Haemodialysis

Are we on the cusp of pharmacological management for AV fistulas? Nick Inston shares what #VascularAccess data he looks forward to in the near future as part of yesterday's Vascular News LIVE broadcast. Watch the discussion here: vascularnews.com/vascularnews-l…

"I'm very intrigued by what's going on in xenotransplantation" Bart Dolmatch looks ahead to the future of care for #haemodialysis patients during yesterday's Vascular News LIVE broadcast. Watch the discussion here: vascularnews.com/vascularnews-l…

“I think we keep our eyes on the evolution of the treatment algorithm” Kate Steiner outlines future priorities in #VascularAccess care during yesterday's Vascular News LIVE broadcast, which can be viewed on demand here: vascularnews.com/vascular-news-…